Not greed - over regulation. There is money to be made on selling generics - it's that none of the entrenched providers have much incentive to do so and barrie

Not greed - over regulation. There is money to be made on selling generics - it's that none of the entrenched providers have much incentive to do so and barriers for new companies to form and get established are ridiculously high, further disincentivizing new players from entering the market. The FDA has been smacked down pretty hard in a few recent court decisions for overstepping their bounds; maybe we'll see more people start to enter the fray and push back against the entrenched establishment.